Intravenous Flurbiprofen Axetil Enhances Analgesic Effect of Opioids in Patients with Refractory Cancer Pain by Increasing Plasma β-Endorphin
Tingting Wu(Wuhan General Hospital of Guangzhou), Bicheng Zhang(University of Electronic Science and Technology of China), Bo Yang(Xijing Hospital), Guoqing Yao(Wuhan General Hospital of Guangzhou), Zhigang Wang(Brigham and Women's Hospital), Jun Wang(Wenzhou Medical University), Jianfei Gao(Shenyang Pharmaceutical University), Wuling Ou(Hubei Cancer Hospital), Zhiguo Rao(Lanzhou University)
Cited by 12
Related Papers
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
|Frontiers in Immunology|2020|256
Clinical characteristics of 82 death cases with COVID-19
|medRxiv|2020|249